Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010 (2010), Article ID 363679, 5 pages
http://dx.doi.org/10.1155/2010/363679
Review Article

Registry Evaluation of Digital Ulcers in Systemic Sclerosis

Division of Rheumatology AOUC, Department of Biomedicine, Denothe Centre, University of Florence, Villa Monna Tessa, viale Pieraccini 18, 50139 Firenze, Italy

Received 17 May 2010; Accepted 2 August 2010

Academic Editor: Virginia D. Steen

Copyright © 2010 Felice Galluccio and Marco Matucci-Cerinic. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Hachulla, P. Clerson, D. Launay, M. Lambert, S. Morell-Dubois, V. Queyrel, and P.-Y. Hatron, “Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study,” Journal of Rheumatology, vol. 34, no. 12, pp. 2423–2430, 2007. View at Google Scholar
  2. U. A. Walker, A. Tyndall, and A. Tyndall, “Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database,” Annals of the Rheumatic Diseases, vol. 66, no. 6, pp. 754–763, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. V. Steen, C. P. Denton, J. E. Pope, and M. Matucci-Cerinic, “Digital ulcers: overt vascular disease in systemic sclerosis,” Rheumatology, vol. 48, supplement 3, pp. iii19–iii24, 2009. View at Google Scholar
  4. D. J. Abraham, T. Krieg, J. Distler, and O. Distler, “Overview of pathogenesis of systemic sclerosis,” Rheumatology, vol. 48, pp. iii3–iii7, 2009. View at Google Scholar
  5. L. Amanzi, F. Braschi, and F. Braschi, “Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions,” Rheumatology, vol. 49, no. 7, pp. 1374–1382, 2010. View at Publisher · View at Google Scholar · View at PubMed
  6. L. Chung and D. Fiorentino, “Digital ulcers in patients with systemic sclerosis,” Autoimmunity Reviews, vol. 5, no. 2, pp. 125–128, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. J. H. Korn, “Scleroderma: a treatable disease,” Cleveland Clinic Journal of Medicine, vol. 70, no. 11, pp. 954–968, 2003. View at Google Scholar
  8. P. A. Merkel, K. Herlyn, and K. Herlyn, “Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon,” Arthritis and Rheumatism, vol. 46, no. 9, pp. 2410–2420, 2002. View at Publisher · View at Google Scholar · View at PubMed
  9. L. Mouthon, C. Mestre-Stanislas, and C. Mestre-Stanislas, “Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 214–217, 2010. View at Publisher · View at Google Scholar · View at PubMed
  10. J. H. Korn, M. Mayes, and M. Mayes, “Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist,” Arthritis and Rheumatism, vol. 50, no. 12, pp. 3985–3993, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. M. T. Duruöz, S. Poiraudeau, J. Fermanian, C.-J. Menkes, B. Amor, M. Dougados, and M. Revel, “Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap,” Journal of Rheumatology, vol. 23, no. 7, pp. 1167–1172, 1996. View at Google Scholar
  12. L. M. Brower and J. L. Poole, “Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma),” Arthritis and Rheumatism, vol. 51, no. 5, pp. 805–809, 2004. View at Google Scholar
  13. M. Matucci-Cerinic, L. Guillevin, C. P. Denton, B. Schwierin, D. Rosenberg et al., “Demographic and previous complication/interventions in patients with digital ulcers and different subsets of scleroderma: preliminary findings from the DUO registry,” in Proceedings of the 1st Systemic Sclerosis World Congress, Florence, Italy, 2010.
  14. C. Sunderkötter, I. Herrgott, and I. Herrgott, “Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors,” British Journal of Dermatology, vol. 160, no. 4, pp. 835–843, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. I. Herrgott, G. Riemekasten, N. Hunzelmann, and C. Sunderkötter, “Management of cutaneous vascular complications in systemic scleroderma: experience from the German network,” Rheumatology International, vol. 28, no. 10, pp. 1023–1029, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. J. Pope, S. Khimdas, S. Harding, A. Bonner, and M. Baron, “Associations with digital ulcers (DU) in a large cohort of systemic sclerosis (SSc): results from thee canadian scleroderma research group (CSRG),” in Proceedings of the 1st Systemic Sclerosis World Congress, Florence, Italy, 2010.
  17. F. M. Wigley, R. A. Wise, and R. A. Wise, “Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double- blind study,” Annals of Internal Medicine, vol. 120, no. 3, pp. 199–206, 1994. View at Google Scholar
  18. M. Matucci-Cerinic, C. P. Denton, D. E. Furst, M. D. Mayes, and V. M. Hsu, “Bosentan treatment of digital ulcerations related to systemic sclerosis: results of a randomised double-blind placebo-controlled trial,” submitted.
  19. S. Guiducci and M. M. Cerinic, “Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis,” Nature Clinical Practice Rheumatology, vol. 4, no. 6, pp. 288–289, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. A. Abou-Raya, S. Abou-Raya, and M. Helmii, “Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers,” Journal of Rheumatology, vol. 35, no. 9, pp. 1801–1808, 2008. View at Google Scholar
  21. A. K. Murray, T. L. Moore, T. A. King, and A. L. Herrick, “Abnormal microvascular response is localized to the digits in patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1952–1960, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. O. Kowal-Bielecka, R. Landewé, and R. Landewé, “EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR),” Annals of the Rheumatic Diseases, vol. 68, no. 5, pp. 620–628, 2009. View at Publisher · View at Google Scholar · View at PubMed
  23. J. Avouac, O. Kowal-Bielecka, and O. Kowal-Bielecka, “European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research,” Annals of the Rheumatic Diseases, vol. 68, no. 5, pp. 629–634, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. J. H. W. Distler, Y. Allanore, and Y. Allanore, “EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells,” Annals of the Rheumatic Diseases, vol. 68, no. 2, pp. 163–168, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. A. L. Herrick, C. Roberts, and C. Roberts, “Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis,” Arthritis and Rheumatism, vol. 60, no. 3, pp. 878–882, 2009. View at Publisher · View at Google Scholar · View at PubMed